In several other studies, the expression of HER-2/neu was associated with the intestinal type of adenocarcinoma and poorer prognosis (Liu et al., 2012; Hsu et al., 2011; Wang and Zhang 2017). This evidence concerns the gene ERBB2 and adenocarcinoma.